Raymond D. Magorien

4.9k total citations · 2 hit papers
65 papers, 3.7k citations indexed

About

Raymond D. Magorien is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Raymond D. Magorien has authored 65 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Cardiology and Cardiovascular Medicine, 25 papers in Surgery and 14 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Raymond D. Magorien's work include Cardiovascular Function and Risk Factors (15 papers), Cardiac Imaging and Diagnostics (13 papers) and Hemodynamic Monitoring and Therapy (11 papers). Raymond D. Magorien is often cited by papers focused on Cardiovascular Function and Risk Factors (15 papers), Cardiac Imaging and Diagnostics (13 papers) and Hemodynamic Monitoring and Therapy (11 papers). Raymond D. Magorien collaborates with scholars based in United States, France and United Kingdom. Raymond D. Magorien's co-authors include Donald V. Unverferth, Carl V. Leier, John Orazem, Tim Crowe, Steven E. Nissen, Peter Ganz, William J. Sasiela, E. Murat Tuzcu, Charles O’Shaughnessy and Paul Schoenhagen and has published in prestigious journals such as New England Journal of Medicine, Circulation and Annals of Internal Medicine.

In The Last Decade

Raymond D. Magorien

65 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Statin Therapy, LDL Cholesterol, C-Reactive Protein, and Coronary Artery Disease

2005 1.0k citations Steven E. Nissen, E. Murat Tuzcu et al. New England Journal of Medicine profile →
Factors influencing the one-year mortality of dilated cardiomyopathy

1984 430 citations Donald V. Unverferth, Raymond D. Magorien et al. The American Journal of Cardiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Raymond D. Magorien United States	28	2.5k	1.3k	595	376	357	65	3.7k
Jack L. Martin United States	24	3.1k 1.2×	1.8k 1.4×	765 1.3×	484 1.3×	281 0.8×	66	4.0k
Tadanori Aizawa Japan	34	2.8k 1.1×	1.1k 0.9×	909 1.5×	265 0.7×	507 1.4×	153	4.0k
Michel F. Rousseau Belgium	39	4.2k 1.7×	1.1k 0.9×	930 1.6×	278 0.7×	457 1.3×	161	5.5k
Jay N. Cohn United States	11	4.1k 1.6×	745 0.6×	396 0.7×	160 0.4×	515 1.4×	16	4.8k
Jules Y.T. Lam Canada	28	1.8k 0.7×	1.2k 0.9×	630 1.1×	155 0.4×	249 0.7×	41	2.9k
Gian Gastone Neri Serneri Italy	34	1.8k 0.7×	661 0.5×	226 0.4×	266 0.7×	324 0.9×	118	3.3k
Maria Anastasiou‐Nana Greece	36	2.5k 1.0×	679 0.5×	242 0.4×	202 0.5×	392 1.1×	173	3.8k
Atsuyuki Wada Japan	29	4.1k 1.6×	717 0.6×	292 0.5×	471 1.3×	728 2.0×	77	5.1k
M D Klein United States	8	4.4k 1.8×	751 0.6×	568 1.0×	132 0.4×	378 1.1×	15	5.0k
Bodh I. Jugdutt Canada	36	3.5k 1.4×	1.4k 1.1×	1.1k 1.9×	183 0.5×	212 0.6×	156	5.1k

Countries citing papers authored by Raymond D. Magorien

Since Specialization

Citations

This map shows the geographic impact of Raymond D. Magorien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raymond D. Magorien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raymond D. Magorien more than expected).

Fields of papers citing papers by Raymond D. Magorien

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raymond D. Magorien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raymond D. Magorien. The network helps show where Raymond D. Magorien may publish in the future.

Co-authorship network of co-authors of Raymond D. Magorien

This figure shows the co-authorship network connecting the top 25 collaborators of Raymond D. Magorien. A scholar is included among the top collaborators of Raymond D. Magorien based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raymond D. Magorien. Raymond D. Magorien is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Boudoulas, Konstantinos Dean, Uksha Saini, Richard J. Gumina, et al.. (2012). Comparison of Impella and intra-aortic balloon pump in high-risk percutaneous coronary intervention: Vascular complications and incidence of bleeding. Acute Cardiac Care. 14(4). 120–124. 16 indexed citations

Kereiakes, Dean J., Louis Cannon, Robert L. Feldman, et al.. (2010). Clinical and Angiographic Outcomes After Treatment of De Novo Coronary Stenoses With a Novel Platinum Chromium Thin-Strut Stent. Journal of the American College of Cardiology. 56(4). 264–271. 50 indexed citations

Cooke, Glen E., Amy K. Ferketich, Melvin L. Moeschberger, et al.. (2006). Effect of Platelet Antigen Polymorphism on Platelet Inhibition by Aspirin, Clopidogrel, or Their Combination. Journal of the American College of Cardiology. 47(3). 541–546. 64 indexed citations

Nissen, Steven E., E. Murat Tuzcu, Paul Schoenhagen, et al.. (2005). Statin Therapy, LDL Cholesterol, C-Reactive Protein, and Coronary Artery Disease. New England Journal of Medicine. 352(1). 29–38. 1005 indexed citations breakdown →

Raman, Subha V., et al.. (2004). Rotational X‐ray coronary angiography. Catheterization and Cardiovascular Interventions. 63(2). 201–207. 23 indexed citations

O’Keefe, James H., Cindy L. Grines, Marcus A. DeWood, et al.. (1996). Poloxamer-188 as an adjunct to primary percutaneous transluminal coronary angioplasty for acute myocardial infarction. The American Journal of Cardiology. 78(7). 747–750. 31 indexed citations

Hoekstra, James W., W B Gibler, Michael R. Sayre, et al.. (1994). Emergency‐department Diagnosis of Acute Myocardial Infarction and Ischemia: A Cost Analysis of Two Diagnostic Protocols. Academic Emergency Medicine. 1(2). 103–110. 51 indexed citations

Magorien, Raymond D., et al.. (1990). Rest and exercise cardiovascular effects of terazosin in congestive heart failure. The American Journal of Cardiology. 65(9). 638–643. 3 indexed citations

Ryan, James, Phillip Shaffer, David Watson, et al.. (1985). Comparison of multiple exercise radionuclide methods for detection of coronary artery disease. 26(5). 42–8. 1 indexed citations

10.

Magorien, Raymond D., James Hermiller, Donald V. Unverferth, & Carl V. Leier. (1985). Regional Hemodynamic Effects of Clonidine in Congestive Heart Failure. Journal of Cardiovascular Pharmacology. 7(1). 91–96. 18 indexed citations

11.

Unverferth, Donald V., Ruth A. Altschuld, Michael Lykens, et al.. (1984). Reperfusion of the human myocardium by saphenous vein bypass grafts. Journal of Thoracic and Cardiovascular Surgery. 87(4). 577–584. 3 indexed citations

12.

Magorien, Raymond D., Donald V. Unverferth, Gregory Brown, & Carl V. Leier. (1983). Dobutamine and hydralazine: Comparative influences of positive inotropy and vasodilation on coronary blood flow and myocardial energetics in nonischemic congestive heart failure. Journal of the American College of Cardiology. 1(2). 499–505. 24 indexed citations

13.

Leier, Carl V., Patricia Huss, James Hermiller, et al.. (1983). Amrinone therapy for congestive heart failure in outpatients with idiopathic dilated cardiomyopathy. The American Journal of Cardiology. 52(3). 304–308. 40 indexed citations

14.

Unverferth, Donald V., et al.. (1983). Regression of myocardial cellular hypertrophy with vasodilator therapy in chronic congestive heart failure associated with idiopathic dilated cardiomyopathy. The American Journal of Cardiology. 51(8). 1392–1398. 27 indexed citations

15.

Leier, C V, Patricia Huss, Raymond D. Magorien, & Donald V. Unverferth. (1983). Improved exercise capacity and differing arterial and venous tolerance during chronic isosorbide dinitrate therapy for congestive heart failure.. Circulation. 67(4). 817–822. 221 indexed citations

16.

Leier, Carl V., et al.. (1982). The Effect of Vasodilator Therapy on Systolic and Diastolic Time Intervals in Congestive Heart Failure. CHEST Journal. 81(6). 723–729. 20 indexed citations

17.

Kolibash, Albert J., Raymond D. Magorien, Charles A. Bush, & John S. Vasko. (1982). Long‐term survival following cardiac rupture with subsequent development of left ventricular pseudoaneurysm. Catheterization and Cardiovascular Diagnosis. 8(4). 409–417. 3 indexed citations

18.

Unverferth, Donald V., Raymond D. Magorien, Albert J. Kolibash, et al.. (1981). Biochemical and histologic correlates of ventricular end-diastolic pressure. International Journal of Cardiology. 1(2). 133–142. 27 indexed citations

19.

Magorien, Raymond D., et al.. (1979). Electrophysiologic studies of perphenazine and protriptyline in a patient with psychotropic drug-induced ventricular fibrillation. The American Journal of Medicine. 67(2). 353–357. 17 indexed citations

20.

Leier, Carl V., et al.. (1979). Interatrial conduction (activation) times. The American Journal of Cardiology. 44(3). 442–446. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact